ISRCTN64382660进行中（未招募）未知
SPCG-17 - Prostate Cancer Active Surveillance Trigger Trial (PCASTT)
ppsala University0 个研究点目标入组 2,000 人开始时间: 2016年9月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
2019 Protocol article in http://dx.doi.org/10.1136/bmjopen-2018-027860 protocol (added 21/09/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •The inclusion criteria are:
- •1. Recently (within 12 months) diagnosed adenocarcinoma of the prostate
- •2. Tumour stage = T2a, NX, M0 (former MX)
- •3. PSA <15 ng/ml, PSA density = 0,2 ng/ml/cc
- •4. Gleason pattern 3+3=6 (any number of cores, any cancer involvement) or Gleason pattern 3+4=7 (<3 cores (or <30 % of cores if more than ten cores are taken), <10 mm cancer in one core)
- •5. Life expectancy >10 years with no upper age limit
- •6. Candidate for curative treatment if progression occurs
- •7. Signed written informed consent
排除标准
- •Participants not fulfilling the inclusion criteria
研究者
相似试验
进行中（未招募）
不适用
SPCG17: Prostate Cancer Active Surveillance Trigger TrialProstate CancerNCT02914873Uppsala University2,000
已完成
不适用
Prostate cancer screening trial using imagingProstate cancerCancerISRCTN43502108Imperial College London408
招募中
2 期
Active surveillance for early prostate cancer: international study (PRIAS-JAPAN)Prostate cancerJPRN-UMIN000002874Kagawa university1,400
暂停
不适用
How do waiting times during diagnosis affect psychological and physiological stress in men with suspected prostate cancer?Prostate cancerCancerISRCTN45953686Örebro University Hospital400
招募中
不适用
The Active Surveillance StudyProstate CancerNCT05810467Institute of Cancer Research, United Kingdom200